Formulations of an AXL/MER inhibitor
The present application relates to pharmaceutical formulations and dosage forms of an AXL/MER inhibitor, or a pharmaceutically acceptable salt, solvate, or hydrate thereof, including methods of preparation thereof, which are useful in the treatment of AXL/MER mediated diseases such as cancer.
Saved in:
Main Authors | , |
---|---|
Format | Patent |
Language | English |
Published |
05.03.2024
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present application relates to pharmaceutical formulations and dosage forms of an AXL/MER inhibitor, or a pharmaceutically acceptable salt, solvate, or hydrate thereof, including methods of preparation thereof, which are useful in the treatment of AXL/MER mediated diseases such as cancer. |
---|---|
Bibliography: | Application Number: US202117563282 |